2026

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update

Vancouver, British Columbia and Rehovot, Israel – August 11, 2026 - BioHarvest Sciences Inc (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced results from the second quarter and six months of 2026.   Dr. Zaki Rakib, Chief Executive Officer of BioHarvest, stated, “We are extremely pleased to have signed a manufacturing agreement this […]

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update Read More »

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance

Vancouver, British Columbia and Rehovot, Israel- August 11, 2026 – BioHarvest Sciences Inc (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced an exclusive manufacturing and supply agreement that secures production of a rare, endangered, fragrance plant cell culture, extending terms of the original Agreement (“the Agreement”) with its

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance Read More »

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference

Vancouver, British Columbia and Rehovot, Israel – July 29, 2026 – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will present at the upcoming Canaccord Genuity 46th Annual Growth Conference, to be held on August 11-13, 2026,

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference Read More »

BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis   

Grant to partially fund research that will enable faster development, with a higher probability of success, of new plant-based compounds (precision botanics) for the benefit of BioHarvest’s CDMO customers and partners Vancouver, British Columbia and Rehovot, Israel- – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today

BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis    Read More »

BioHarvest Sciences to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC

Vancouver, British Columbia and Rehovot, Israel – July 13, 2026 – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will participate in a fireside chat at the upcoming Maxim Health, Wellness & Longevity Conference, to be held

BioHarvest Sciences to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC Read More »

BioHarvest Sciences to Present at the 2026 BIO International Convention

Vancouver, British Columbia and Rehovot, Israel – June 18, 2026 – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details: BioHarvest Sciences’ presentation will showcase

BioHarvest Sciences to Present at the 2026 BIO International Convention Read More »